Furthermore, as abovementioned, the promoter of the CYP2E1 gene is hypomethylated in the brain of PD patients [24], and its protein product cytochrome P450 2E1 is involved in the formation of toxic metabolites contributing to dopaminergic degeneration [16]. Here, CYP2E1 is linked to Parkinson disease.